Not applicableStudy completedNCT01146990
What this trial is testing
A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth
Who this might be right for
Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial
AMAG Pharmaceuticals, Inc. 245